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RegulationAU1c of Mouse Microglia Activation
and Effector Functions by Bone Marrow-Derived
Mesenchymal Stem Cells
AU2c Bea´ta Hegyi,1 Zsuzsanna Ko¨rnyei,2 Szilame´r Ferenczi,3 Rebeka Fekete,2 Gyo¨ngyi Kudlik,1,4
Krisztina J. Kova´cs,3 Emı´lia Madara´sz,2 and Ferenc Uher4
Mesenchymal stems or stromal cells (MSCs) are rare multipotent cells with potent regenerative and immu-
nomodulatory properties. Microglial cells (MGs) are specialized tissue macrophages of the central nervous
system (CNS) that continuously survey their environment with highly motile extensions. Recently, several
studies have shown that MSCs are capable of reprogramming microglia into an ‘‘M2-like’’ phenotype char-
acterized by increased phagocytic activity and upregulated expression of anti-inflammatory mediators in vitro.
However, the precise polarization states of microglia in the presence of MSCs under physiological or under
inflammatory conditions remain largely unknown. In this study, we found that MSCs induce a mixed microglia
phenotype defined as Arg1-high, CD86-high, CD206-high, IL-10-high, PGE2-high, MCP-1/CCL2-high, IL-1b-
moderate, NALP-3-low, and TNF-a-low cells. These MSC-elicited MGs have high phagocytic activity and
antigen-presenting ability. Lipopolysaccharide is able to shape this microglia phenotype quantitatively, but not
qualitatively in the presence of MSCs. This unique polarization state resembles a novel regulatory microglia
phenotype, which might contribute to the resolution of inflammation and to tissue repair in the CNS.
IntroductionAU3c
Mesenchymal stem cells (MSCs) are rare multipotentstromal cells with potent regenerative and immuno-
modulatory properties. They were originally isolated from
the bone marrow (BM) [1] and later from multiple other
tissues and organs [2–4]. Their capacity to differentiate into
a number of mesodermal and extramesodermal lineages
has initiated great interest in the use of these cells for the
treatment of a wide variety of degenerative disorders [5,6].
Recently, however, it became clear that the mechanisms in-
volved in the reparative effects of MSCs are mainly related
to their trophic effects on other cells, as well as to their anti-
inflammatory and immunoregulatory activity [7]. It has
been demonstrated that MSCs exert their immunomodulatory
effects on multiple populations of T and B lymphocytes [8–
10],AU4c NK cells [11], and other leukocytes [10,12] through
multiple mechanisms, including various soluble factors and/
or direct cell–cell contact. Important mediators secreted by
MSCs are prostaglandin E2 (PGE2) [13,14], indolamine 2,3-
dioxygenase enzyme [15,16], nitric oxide [17,18], trans-
forming growth factor-beta, and hepatocyte growth factor
[8,19]. In addition, MSCs have been shown to express the
coinhibitory molecules B7-H1 and B7-H4 [20,21], the notch
ligand Jagged-1[22], and galectin-1 [23] on their surface,
which negatively interfere with immune responses. Further-
more, maximum anti-inflammatory and immunosuppressive
effects can be evoked if MSCs are activated in a pro-
inflammatory microenvironment by the presence of cyto-
kines such as interferon-gamma, tumor necrosis factor-alpha
(TNF-a), and/or interleukin-1-beta (IL-1b) [24,25]. In turn,
MSCs seem to provide signals that stimulate the conversion
of macrophages to an anti-inflammatory/regulatory pheno-
type [12,26,27].
Mononuclear phagocytes are now not only recognized as
crucial cellular components of tissue repair and regeneration
in each organ, but can also contribute to tissue damage. They
can adopt a variety of functional phenotypes in response to
environmental cues. The classical M1 and M2 (pro- and anti-
inflammatory, respectively) polarization states represent two
ends of a functional spectrum of cell activation [28].
Under stress or injury, the activation of microglial cells
(MGs), the resident mononuclear phagocytes within the
central nervous system (CNS), can result in the production
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of pro-inflammatory mediators that are toxic to neurons
and contribute to the pathology of many neurodegenerative
diseases. In contrast, under normal physiological conditions,
MGs serve an important role in immune surveillance and
homeostasis within the CNS by continually surveying their
microenvironment [29,30]. Therefore, modulating microglia
polarization state may limit inflammation and tissue damage
within the CNS.
Recently, several studies have shown that MSCs are ca-
pable of reprogramming MGs into an ‘‘M2-like’’ phenotype
characterized by increased phagocytic activity and upregu-
lated expression of anti-inflammatory mediators in vitro.
However, the precise polarization states of microglia in the
presence of MSCs under physiological or inflammatory
conditions remain largely unknown. In most studies, xeno-
genic experimental systems were used; that is, cocultures of
human MSCs with mouse or rat MGs [26,31–33] and pri-
mary microglia were frequently replaced with neoplastic
cell lines (BV2 or N9) [34–36] or with hippocampal slices
[37]. Only two laboratories used autologous mouse [35] or
rat [38] primary MGs and MSCs. The different experimental
approaches may explain the sometimes conflicting results
obtained by different groups.
Our recent work was focused on the in vitro interactions of
autologous BM-derived MSCs with primary MGs. The surface
phenotype, phagocytic activity, pro- and anti-inflammatory
mediator secretion ability, and antigen-presenting capacity
of resting and endotoxin-stimulated mouse MGs were studied
in the presence or absence of mouse BM-derived MSCs. We
found that MSCs elicit a mixed microglia phenotype char-
acterized by anti-inflammatory activity but increased phago-
cytic and antigen-presenting ability. Lipopolysaccharide
(LPS) is able to shape this MG phenotype quantitatively, but
not qualitatively in the presence of MSCs enhancing pro-
inflammatory mediator production while not inducing a
typical M1 phenotype.
Materials and Methods
Animals
Adult (10–12 weeks old) C57BL/6 (H-2b) (National In-
stitute of Oncology, Budapest, Hungary) and neonatal (1–3
days old) CD1, C57Bl/6, and CX3CR1+ /GFP transgenic mice
(on C57BL/6 background) (Institute of Experimental Medi-
cine, Budapest, Hungary) were used according to the guide-
lines of the Animal Care and Use Committee of the National
Blood Service (Budapest, Hungary). CX3CR1+ /GFP animals
[39] were obtained from the European Mouse Mutant Ar-
chive (EMMA cx3cr1tm1Litt MGI:2670351) and back-
crossed for more than 10 generations to C57Bl/6.
Isolation and culturing of MSCs
We established MSC cultures from the BM of adult
C57Bl/6 (H-2b) mice. The isolation and characterization
of these cells were carried out according to Hegyi et al.
[40]. Briefly, after the decapitation of the animals, mono-
nuclear cells were isolated by flushing the femurs with
complete medium (CM) containing DMEM/Ham’s F-12
medium (Invitrogen), 10% fetal bovine serum, 5% horse
serum (Invitrogen), 50 U/mL penicillin, 50mg/mL strepto-
mycin (Sigma-Aldrich), and 2 mM l-glutamine (Invitrogen)
supplemented with heparin at a final concentration of
5 U/mL. To remove tissue debris, the suspension was fil-
tered through a 60 mm nylon mesh. The obtained cells were
washed twice in Hanks’ balanced saline (Invitrogen) and
plated in a 25-cm2 flask (BD Falcon) at a density of 2–
4 · 106 cells/cm2 in CM. After incubation in a humidified
5% CO2 incubator at 37C for 72 h, the nonadherent cells
were removed by replacing the CM; this process was then
repeated every 3 days. The confluent adherent primary
cultures were washed with cold Hanks’ balanced saline,
then dissociated in 0.25% Trypsin-EDTA solution (In-
vitrogen), and replated in 75 cm2 culture flasks at a dilution
of 1:5. Cultures were regularly split after reaching con-
fluency. Cultures after 8–15 passages were used for the
experiments.
Preparation of mixed glial cell cultures
and isolation of microglia
The preparation of mixed glial cell cultures and the
isolation of microglia were carried out according to Saura
et al. [41] with some modifications. The brains of neonatal
(P1–P3) CD1 mice were isolated and then the meninges
and choroid plexus were removed. The forebrain tissue was
cut into mm3 size pieces and digested (10 min, 37C) by
0.05% trypsin in phosphate-buffered saline (PBS) con-
taining 400 mg/mL DNAse (Sigma-Aldrich). Cells were
suspended in CM without horse serum and seeded into
poly-l-lysine (PLL) (Sigma-Aldrich)-coated Petri dishes
(BD Falcon). At the 24th and 48th hours, the nonadherent
cells were removed by a thorough washing of the surface
with culture media. After 3 weeks of incubation, the ma-
ture mixed glial cultures were treated with 0.05% EDTA-
free Trypsin solution for 2 h at 37C whereupon layers
containing predominantly astroglial cells floated up from
the bottom of the dishes. After the removal of the astroglia-
rich floating cells, the remaining adherent microglia cells
were washed off by incubation with 0.25% Trypsin/EDTA
solution at 37C for 10 min. The obtained MGs were wa-
shed and re-seeded to PLL-coated plates in CM without
horse serum.
Flow cytometric analysis
1–2 · 105 cells were stained in FACS buffer (PBS with
0.5% v/w bovine serum albumin) for 20 min at 4C with
monoclonal antibodies for Sca-1, CD11b, CD34, CD44,
CD45, CD73, CD86, CD206, F4/80, Gr1, Ter119, and
MHC-II purchased from BD Pharmingen. After incubation,
samples were washed with FACS buffer and analyzed on an
FACScan flow cytometer using CellQuest software (Becton
Dickinson).
In vitro stimulation of MGs
MGs were seeded at 105 cells/mL in 24-well flat-bottom
plates (BD Falcon) in CM with or without 104 MSCs in the
presence or absence of 1 mg/mL LPS and cultured for 48 h at
37C. To investigate the effect of spatial separation, we
prepared transwell experiments, where 104 MSCs were
plated into transwell chambers with 1 mm pore-sized mem-
brane suitable for 24-well plates (BD Falcone) and 105 MGs
were added into the lower compartment.
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Immunocytochemical staining
and cell area calculations
105 MGs were incubated at 37C for 48 h in the pres-
ence or absence of 104 BM-derived MSCs and/or 10 mg/mL
LPS. The cultures were fixed with 4% paraformaldehyde
in PBS solution at room temperature for 20 min and were
then incubated with the cell surface marker Isolectin B4
(Sigma L-2140; biotin conjugated) diluted (1:500) over-
night in PBS containing 5% fetal calf serum at 4C. For
fluorescent detection, after washing with PBS, Alexa 488-
conjugated avidin (Invitrogen; 1:1,000) was used for 60 min
at room temperature. The preparations were covered with
bis-benzimidazole (Sigma-Aldrich) containing Mowiol (Merck
KGaA). For each individual culture, independent images
(n = 15) of random fields of view were taken with a Nikon
A1R confocal laser-scanning system built on a Ti-E inverted
Nikon microscope, having a 0.45 NA 20· CFI Super Plan
Fluor ELWD (Nikon GmbH) objective and NIS elements
(Nikon) software. Cell number was calculated by counting
bis-benzimide (Hoechst)-stained nuclei. Individual cell areas
were measured by Zeiss AxioVision 4.8 software.
Yeast phagocytosis of MGs
Saccharomyces cerevisiae cells were heat inactivated by
boiling for 30 min and then resuspended in PBS at the final
concentration of 5·107cell/mL. From this solution, 0.1 mL
(5·106 yeast cells) was added to the wells containing microglia
and/or MSCs and incubated at 37C for 1 h. Subsequently,
noningested yeast cells were removed by repeated washing with
PBS, and the cultures were fixed with 8% formalin (v/v in PBS)
solution for 10 min. After three additional washes with PBS,
Giemsa solution was added to the specimens for 1 h. Then, we
took images of 10 random microscopic fields per sample using
a 20· objective of an Olympus CK2 inverted microscope
(Olympus) and a Nikon Coolpix 4500 digital camera (Nikon).
In the photographs, the number of incorporated yeast particles
by single MGs were counted (n= 100 in each experimental
group). Averages and standard deviations were calculated, and
the significance was estimated by Student’s t-test.
Phagocytosis of apoptotic thymocytes by MGs
Thymuses were obtained from 10 to 12 week-old C57BL/
6 mice and minced to get a single cell suspension. To induce
apoptosis, cells were incubated in CM supplemented with
2 mM dexamethasone (Sigma-Aldrich) at a concentration of
5 · 106 cells/mL for 8 h. After washing, 5 · 106 thymocytes
were added to the wells containing microglia and/or MSCs
and incubated for an additional 48 h at 37C.
Detection of secreted proteins
in cell culture supernatants
The amounts of CCL2 [monocyte chemoattractant
protein-1 (MCP-1)], TNF-a, IL-1b, IL-10, and PGE2 in
various cell culture supernatants were measured with Para-
meterTM quantitative ELISA Kits (R&D Systems, Inc.) that
were specific for the respective cytokine. Mouse arginase 1
ELISA Kit was obtained from the Ho¨lzel Diagnostika
GmbH. The experiments were carried out according to the
supplier’s instructions.
Quantitative real-time polymerase chain reaction
Total RNA was isolated with GeneAid Total RNA Mini
Kit from microglia and MSC mono-cultures and from MG/
MSC cocultures at 5 h after plating. The purity of RNA sam-
ples was checked, and concentrations were determined by a
Nano Drop 2000 spectrophotometer (Thermo Scientific). One
hundred fifty nanograms of RNA samples were converted to
cDNA with High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). Real-time polymerase chain reaction
(PCR) was performed with Power SYBR Green PCR Master
Mix (Applied Biosystems) on ABI StepOne instrument ac-
cording to the manufacturer’s instructions. Primer sequences
were designed by Primer Express 3.0 software:
GAPDH:
(f ) TGACGTGCCGCCTGGAGAAA;
(r) AGTGTAGCCCAAGATGCCCTTCAG
TNF-a:
(f ) CAGCCGATGGGTTGTACCTT
(r) GGCAGCCTTGTCCCTTGA
IL-10:
(f ) AGTGAGAAGCTGAAGACCCTCAGG
(r) TTCATGGCCTTGTAGACACCTTGGT
IL-1b:
(f ) TTGACGGACCCCAAAAGATG
(r) TGGACAGCCCAGGTCAAAG
NLRP3:
(f ) CAGAGCCTACAGTTGGGTGAA
(r) ACGCCTACCAGGAAATCTCG
Arg1:
(f ) GTCTGGCAGTTGGAAGCATCT
(r) GCATCCACCCAAATGACACA
MCP-1:
(f ) CCAGCACCAGCACCAGCCAA
(r) TGGATGCTCCAGCCGGCAAC
Gene expression was analyzed by ABI StepOne program.
GAPDH was used as an internal control. To confirm the
identity of PCR products, a melting curve analysis had been
performed with StepOne instrument’s Software v.2.0.
Antigen presentation
For testing the effect of MSCs on the antigen presentation of
MGs toward T cells, 104 MSCs, 105 MGs, and 2· 105 in vivo
primed T cells were cultured along with different concentra-
tions of ovalbumin (OVA) in the indicated combinations (see
Results section) at 37C for 5 days. T cells were obtained from
the lymph nodes of C57Bl/6 mice at 7 days after a subcutaneous
injection of a mixture of complete Freund’s adjuvant and OVA
(in a ratio of 1:1). After the incubation, cultures were pulsed
with 1 mCi 3H-thymidine (Amersham) for 18 h. Cells were
harvested, and thymidine incorporation was quantified in
counts per minute (cpm–SD; n= 3). The amount of regulatory
T cells was determined by FACS using the Mouse Regulatory
T-Cell Staining Kit #1 (eBioscience).
T-cell proliferation
5· 104 MSCs were seeded in 96-well flat-bottom plates
(BD Falcon) and cultured for 24 h at 37C. After 24 h,
MICROGLIA ACTIVATION AND EFFECTOR FUNCTIONS 3
SCD-2014-0088-ver9-Hegyi_1P.3d 06/23/14 6:10am Page 3
nonadherent cells were washed off. To isolate T lymphocytes,
splenocytes derived from adult C57Bl/6 (H-2b) and Balb/c
(H-2d) mice were isolated by disaggregation of spleens; then,
erythrocytes were depleted by NH4Cl lysis (0.15 M NH4Cl in
0.01 M Tris–HCl buffer, pH= 7.5). To purify T lymphocytes,
SpinSep Mouse CD3+ T-Cell Enrichment Kits were used
according to the manufacturer’s protocol (Stem Cell Tech-
nologies). In mitogen-driven proliferation assays, 106 T lym-
phocytes (>95% CD3+ cells by flow cytometry) were seeded
in 200mL CM in the presence of 5mg/mL concanavalin A
(ConA; Sigma-Aldrich) (n= 3). 2–3· 105 responder and 2–
3· 105 irradiated (30 Gy) stimulator splenocytes per well
were seeded in a total volume of 200mL medium to prepare
mixed lymphocyte reactions (MLR). After an incubation of 2
(for mitogen-driven cultures) or 4 (for MLR) days, cultures
were pulsed with 1mCi 3H-thymidine (Amersham Pharmacia
Biotech Export GmbH) for 8 h. Thymidine incorporation of
harvested cells was measured in a Packard Tricarb beta
counter (Perkin-Elmer), to indicate proliferation in cpm. Re-
sults were expressed as mean values–SD.
Statistical analysis
Data are expressed as mean – SD. The differences be-
tween groups were evaluated by a two-tailed Student’s t-
test. The significance level was set at P< 0.05.
Results
Characterization of MSCs and MGs
MSCs derived from the BM of adult C57Bl/6 mice were
positive for MSC markers (Sca-1, CD44, and CD73), but
negative for several hematopoietic markers (CD34, CD45,
CD11b, F4/80, Gr1, Ter119, and CD206), and could dif-
ferentiate into adipocytes and osteoblasts in vitro (data not
shown), as previously described [40,42].
The majority (70%–80%) of cultured MGs derived from
neonatal CD1 or C57Bl/6-CX3CR1 + /GFP mice were posi-
tive for F4/80, a marker for murine microglia, and partially
positive for CD11b and CD206. However, only a very low
level of MHC class II antigen expression was observed on
the surface of MGs, indicating that they are mainly in
resting state (F1c Fig. 1A). The identity of MGs was further
confirmed by a yeast phagocytosis assay (see belowAU5c ).
MSCs induce morphological and functional
changes in microglia
To test whether MSCs can induce morphological changes
of MGs, cocultures of MGs with MSCs (ratio = 10:1) were
established. The shape, size, and phagocytotic activity of
MGs were compared between pure MG cultures and MSC-
MG cocultures. In mono-type cultures, the majority of
MGs (SF1c Supplementary Fig. S1A, C; Supplementary Data are
available online at www.liebertpub.com/scd) had a rather
small, compact perikaryon with thin, ramifying processes;
whereas in the presence of MSCs, they displayed an en-
larged, flattened cell shape with thick irregular protrusions
(Supplementary Fig. S1B, D). Next, we repeated the co-
culture experiment using GFP-positive MGs derived from
C57Bl/6-CX3CR1 + /GFP mice (Supplementary Fig. S1E, F).
To quantify this difference, the size of the MGs in the cul-
tures were determined in images taken with a Nikon A1R
confocal laser-scanning system with the help of Zeiss Axio-
Vision 4.8 software after Isolectin-B4 staining. As shown in
Fig. 1B and Supplementary Fig. S1C and D, the average size
of MGs almost doubled in the presence of MSCs (1,682– 74
vs. 2,858– 101, n= 3, P< 0.001) compared with MGs cul-
tured alone.
Furthermore, the presence of MSCs markedly increased
the yeast phagocytosis of microglia (Fig. 1C and b SF2Supple-
mentary Fig. S2A, B). Since the recognition of yeast cells
involves a number of receptors, including the CD206
mannose receptor, we analyzed the expression of CD206 on
the surface of MGs in the presence or absence of MSCs. We
found that, after 48 h of coculturing with MSCs, the expres-
sion of CD206 significantly increased in F4/80-positive MGs
compared with microglia cultured alone (45.1%– 2.8% vs.
34.9%– 3.1%, n= 5, P< 0.001) (Fig. 1D).
The release of pro- and anti-inflammatory mediators by
MGs was assessed after yeast cell and apoptotic thymo-
cyte phagocytosis, in the presence and absence of MSCs.
In nonphagocytotic MSC/MG cocultures, slightly elevated
levels of TNF-a and PGE2, and highly (by about two
magnitude orders) increased levels of IL-10 were measured
in comparison to both MG and MSC mono-cultures. In
response to 24- and 48-h exposure to yeast cells, mono-
cultured MGs showed a more than 6- and 25-fold increase of
TNF-a ( b F2Fig. 2A, D) and an about 3- and 5-fold elevation in
IL-10 (Fig. 2B, E) production, respectively. As expected,
apoptotic thymocytes alone did not evoke measurable
changes in either TNF-a or IL-10 production in MG mono-
cultures. In the cocultures, however, they caused a signifi-
cant increase in the production of IL-10 and PGE2. In MG/
MSC cocultures, yeast loading resulted in a much higher
increase in the production of TNF-a and PGE2 (in com-
parison to yeast-loaded mono-MG cultures), while the high
IL-10 generation of MG/MSC cocultures was not further
increased by yeast loading. The data indicated that the
presence of MSCs can alter the cytokine production of MGs,
shifting the TNF-a/IL-10 ratio toward an anti-inflammatory
cytokine status. It should be noted that no production of
cytokines was observed when MSCs were cultured alone.
Since PGE2 seems to play a key role in MSC–macrophage
interaction in several other experimental systems [12,43], we
also measured the level of this lipid mediator in the collected
supernatants of our cultures. As shown in Fig. 2C and F,
PGE2 production was detected in all cultures, especially
when MGs were cultured in the presence of MSCs. The
highest PGE2 level was found in cocultures containing yeast
phagocytosing microglia, although MSCs and MGs alone
were also able to produce significant amounts of PGE2.
Therefore, these results might indicate some relevance of
PGE2 in the MG–MSC interaction.
MSCs modulate the release of cytokines
and PGE2 by LPS-stimulated microglia
Next, we assessed whether MSCs affect the TNF-a,
IL-10, and PGE2 production of microglia when activated
by bacterial endotoxin for 48 h. LPS-stimulated MGs pro-
duced significantly higher amounts of TNF-a compared with
resting microglia ( b F3Fig. 3). A concomitant moderate increase
in IL-10 and PGE2 levels was also observed in response to
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LPS. Interestingly, neither TNF-a nor IL-10 was detected in
the supernatants of LPS-stimulated MSC monocultures (data
not shown). When MGs were cocultured with MSCs in the
absence of LPS, IL-10 and PGE2 levels significantly in-
creased in the culture media; whereas the production of
TNF-a remained unchanged compared with microglia mono-
cultures. When MGs and MSCs were cocultured in the
presence of LPS, the amount of all three mediators increased
dramatically. In LPS-treated transwell cultures, the MSC-
induced IL-10 and PGE2 increase was significantly reduced,
but not completely eliminated; whereas the amount of TNF-
a was unchanged in comparison to contact cocultures. The
data indicated that both soluble mediator(s) and direct cell-
to-cell contact(s) play crucial roles in MG–MSC interaction.
In order to further clarify the earlier findings, we used a
two-step transwell culture system. In the first step, MGs and
MSCs were cocultured in the presence or absence of LPS in
transwell plates, enabling only humoral cell contacts. After
48 h, the MSC-containing inserts were transferred into new
wells without microglia and fresh media was added to all
MSC and MG cultures. After an additional incubation for
24 h, the TNF-a, IL-10, and PGE2 concentrations were
measured in the media by ELISA. As shown inF4c Fig. 4, only
MGs secreted significant amounts of TNF-a (Fig. 4A) and
IL-10 (Fig. 4B) regardless of the presence or absence of
LPS. In contrast, PGE2 was produced by both cell types
(MG and MSC) and the production increased in response to
LPS stimulation (Fig. 4C). To further validate these results,
we measured the TNF-a and IL-10 gene expression by
quantitativeAU4c RT-PCR. In accordance with the ELISA data,
no TNF-a or IL-10-specific mRNAs were detected in MSCs,
whereas high levels of these messages were observed in
MGs (data not shown). Thus, MSCs were unable to produce
TNF-a or IL-10 in our experimental system.
Since recent data showed that PGE2 signaling plays an
important role in the regulation of IL-10 secretion by
phagocytes [12,43], next we compared the kinetics of IL-10
and PGE2 production in MG–MSC cocultures after 4, 24,
48, and 72 h of incubation. We observed that levels of PGE2
significantly increased in the coculture medium during the
first 24 h of coculture (MG+MSC), and were further en-
hanced in response to LPS (MG+MSC +LPS) ( b F5Fig. 5B).
The presence of MSCs could upregulate the production of
IL-10 by MGs in both the presence and absence of LPS
(MG and MG+LPS), but only during the second and third
days of coculturing (Fig. 5A). The data suggested that PGE2
could be an inductor of microglial IL-10 secretion in MG/
MSC cocultures.
MSCs increase arginase 1
and MCP-1 expression in MGs
Since arginase 1 (Arg1) is known as a marker of alter-
natively activated phagocytes, we assessed whether the
presence of MSCs could change the microglial expression of
the enzyme [44]. As shown in b F6Fig. 6A, the Arg1 mRNA
expression was markedly upregulated by MSCs (MG+
MSC) if compared with the levels observed in mono-
cultures of either MGs or MSCs. The presence of MSCs
induced a similar (more than threefold) enhancement of the
FIG. 1. MSCs induce morphological and
functional changes on microglia. (A) Ana-
lysis of the phenotype of MGs by flow cy-
tometry. Representative flow cytometry
histograms were obtained using individual
antibodies ( bAU6colored lines) compared with the
corresponding isotype control (shaded in
gray). (B) Spreading of microglia. MGs were
cultured alone or in the presence of 104 bone
marrow MSCs for 48 h. The areas of indi-
vidual cells were measured by appropriate
software on images taken by a confocal laser-
scanning microscope (n = 100, **P< 0.001).
(C)Changes in the phagocytosis of yeast cells
by microglia. 105 MGs were cultured with or
without 104 MSCs for 48 h and then 5 · 106
yeast cells were added. After 1 h, cultures
were fixed and stained with Giemsa solution.
The intensity of phagocytosis was quantified
by counting ingested yeast particles in indi-
vidual photographs (n = 100, **P< 0.001).
(D) Representative dot plots of MGs alone or
together with MSCs for F4/80 and CD206
markers by flow cytometry. MGs, microglial
cells; MSCs, mesenchymal stem cells.
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FIG. 2. The cytokine production of MGs
is different after phagocytosis of yeast
or apoptotic thymocytes. 105 MGs were in-
cubated for 24 h (A–C) or 48 h (D–F) after
phagocytosis of yeast or apoptotic thymo-
cytes in the presence or absence of 104
MSCs. After the culturing period, we col-
lected supernatants and measured the
amount of TNF-a (A, D), IL-10 (B, E), and
PGE2 (C, F) by quantitative ELISA kits
according to the manufacturer’s instructions.
The results are shown as mean – SD (n = 3,
*P < 0.05 and **P < 0.001 compared with
MG control). IL, interleukin; PGE2, prosta-
glandin E2; TNF-a, tumor necrosis factor-
alpha.
FIG. 3. MSCs modulate the release of
cytokines and PGE2 by LPS-stimulated
microglia. MGs (105/well) were incubated
alone or with MSCs (104/well) in the pres-
ence or absence of 10 mg/mL LPS in the
indicated combinations for 48 h. In transwell
experiments, the two cell types were sep-
arated from each other by a 1 mm pore-sized
semi-permeable membrane. The concentra-
tions of TNF-a, IL-10, and PGE2 in the
collected supernatants were measured with
quantitative ELISAs. The results are shown
as mean– standard deviation (n= 3, *P< 0.05
and **P< 0.001 compared with MG control).
LPS, lipopolysaccharideAU7c .
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Arg1 gene expression in LPS-stimulated MGs (MG+
MSC +LPS). The presence of MSCs increased the Arg1
expression in MGs even if contact communication was
prevented by cocultivating the cells in transwell dishes. In
contrast, LPS stimulation reduced the Arg1 expression of
MGs in both mono- and noncontact (trans-well) cocultures.
Interestingly, the presence of MSCs significantly (by
about 2.5-fold) upregulated the transcription of MCP-1/
CCL2 (Fig. 6B), a chemokine involved in leukocyte re-
cruitment [45]. Moreover, the relative MCP-1/CCL2 mRNA
levels increased further (to about 4.0-fold), if LPS was
added to the cocultures. The effect of MSCs on LPS-activated
MGs was slightly attenuated when the cells were separated
in transwell dishes. LPS alone (MG +LPS) could induce
only a 1.5-fold increase in the MCP-1/CCL2 expression in
microglia. Similar results were obtained when Arg1 and
MCP-1 concentrations were measured in the culture super-
natants by quantitative ELISA (Fig. 6C, D).
MSCs exert opposite effects on IL-1b
and NALP3 expression of microglia
Since previous data [35] demonstrated an elevated IL-1b
production by LPS-stimulated MGs in the presence of
FIG. 4. Cytokines are mainly produced by
microglia in the two-step transwell culture sys-
tem. To clarify the identity of mediator pro-
ducing cell(s) in the MG–MSC cocultures, MGs
(105/well) and MSCs (104/well) were coin-
cubated in the transwell for 48 h in the presence
or absence of 10mg/mL LPS; then, the culture
media was replaced. In half of the samples, the
two cell types remained together in the same
wells (MG+MSC in trans-well); whereas in the
other half of the samples, MSC-containing in-
serts were transferred to new, empty wells
[MSC (insert)] and, thus, separated from the
MGs that stayed in the original wells [MG
(well)]. After an additional 24 h of incubation,
we collected samples from the supernatants
and measured the concentrations of TNF-a,
IL-10, and PGE2 by ELISA. The results are
shown as mean– standard deviation form (n=3
*P<0.05 compared with appropriate control) bAU7.
FIG. 5. The time kinetic analysis indicates
a connection between PGE2 and IL-10
production. MGs (105/well) were cultured
alone or with MSCs (104/well) in the pres-
ence or absence of 10mg/mL LPS in the in-
dicated combinations. Supernatants were
collected after the 4th, 24th, 48th and 72nd
hours of incubation. The amounts of IL-10
and PGE2 were measured with quantitative
ELISAs. Values are expressed as mean–SD
of three independent experiments (*P<0.05
compared with appropriate control) bAU7.
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MSCs, we assessed whether MSCs have an impact on the
transcription of IL-1b and NALP3 in resting and LPS-
stimulated microglia. We found that IL-1b mRNA-level in
MGs was similarly (seven- to eightfold) enhanced in the
presence of LPS or MSCs (F7c Fig. 7A, MG+LPS and MG +
MSC). When MGs and MSCs were cocultured in the pres-
ence of LPS, however, the IL-1b expression dramatically
increased (by about 40-fold), indicating that the endotoxin
and stem/stromal cells act synergistically in activation of
microglial IL-1b mRNA expression. In contrast, the level of
IL-1b protein in the supernatants was increased by only
fourfold under identical conditions (Fig. 7B). LPS also in-
creased the expression of NALP3 mRNA (Fig. 7C, MG +
LPS). In contrast to the synergism in IL-1b regulation,
however, the presence of MSCs resulted in a significant
downregulation of NLRP3 gene expression in MGs, in both
the presence (MG +MSC +LPS) and absence (MG +MSC)
of LPS. This effect of MSCs was also confirmed in a
transwell system. The data indicated that MSCs exert op-
posite effects on IL-1b and NALP3 mRNA expression by
MGs and that the net IL-b protein secretion is a result of
these opposite effects.
MSCs enhance the antigen-presenting capacity
of MGs toward in vivo preactivated T lymphocytes
To investigate whether microglial antigen-presenting
ability was modulated by MSCs, we analyzed their capacity
to induce proliferation of in vivo OVA primed T lympho-
cytes in the presence or absence of MSCs. To this end, T
cells (95% CD3 + ) were purified from the inguinal and
popliteal lymph nodes of mice immunized with a mixture of
FIG. 6. MSCs increase
Arg1 and MCP-1 expression
in MGs. MGs (105/well) were
cultured alone or with MSCs
(104/well) in the presence or
absence of 10 mg/mL LPS in
cocultures or in a transwell
arrangement for 5 h. RNA
samples were isolated using
Trizol reagent. After purifi-
cation and reverse transcrip-
tion, real-time PCR was
performed. The figure shows
fold changes in the expres-
sion of Arg1 (A) and MCP-1
(B) genes compared with
MG control. Results obtained
for Arg1 and MCP-1 mRNA
expression were also con-
firmed at protein level by
quantitative ELISA after 48 h
of incubation (C, D). The re-
sults are shown as mean–
standard deviation of three
independent experiments
(*P< 0.05 and **P< 0.001).
Arg1, arginase 1; MCP-1,
monocyte chemoattractant
protein-1; PCR, polymerase
chain reaction.
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OVA and CFA 7 days earlier, and cocultured with MGs (104
cells/well), or MGs and MSCs (103 cells/well) in the pres-
ence of 4, 20, and 100mg/mL OVA, respectively. As shown
inF8c Fig. 8A, MGs were able to induce antigen-specific T-cell
(2 · 105 cells/well) proliferation in a dose-dependent manner
when soluble OVA was also present in the cultures. Sur-
prisingly, when MSCs were also added to the system, T-
lymphocyte proliferation induced by the OVA-presenting
microglia significantly increased (about twofold) compared
with the control (T-cell +MG+OVA) cultures. In addi-
tion, the percentage of CD4 +CD25highFoxp3+ (regulatory)
T cells also slightly but reproducibly increased in the co-
cultures (1.15– 0.12 vs. 1.63– 0.21, P < 0.05, n= 5) (SF3c Sup-
plementary Fig. S3). MSCs alone, however, were unable to
induce expansion of OVA-specific T lymphocytes. In con-
trast, the same MSCs could markedly inhibit mitogen-
(ConA) and alloantigen-induced (MLR) T-cell proliferation
(Fig. 8B, C) at an identical (1:20) MSC: T lymphocyte ratio,
as expected. Thus, MSCs seem to be able to enhance the
antigen-presenting ability of MGs in cocultures where ac-
tivated T cells are present.
To further validate these results, we measured whether
MSCs affect the expression of MHC class II antigen and/or
CD86 by MGs in coculture. We found that MSCs did not
modify significantly MHC class II antigen expression on the
surface of MGs (data not shown), whereas the expression of
costimulatory CD86 molecules was significantly upregu-
lated. The percentage of CD86 + MGs, as well as the mean
fluorescence intensity, that is, the surface density of CD86
molecules on the microglia were increased in the presence
of MSCs (72.3% – 4.8% vs. 94.1% – 4.3%, P < 0.05 and
63.8 – 5.1 vs. 127.5 – 6.7, P < 0.001, n = 3) (Fig. 8D). In
addition, neither MHC class II nor CD86 expression
by MSCs was observed under any culture conditions used
in this work (data not shown). This suggests that MSCs
are able to regulate the antigen-presenting ability of mi-
croglia by increasing their costimulatory molecule (CD86)
expression.
Discussion
MGs are specialized tissue macrophages of the CNS that
continuously survey their environment with highly motile
extensions. In contrast to neurons and macroglial (astro- and
oligodendroglia) cells, MGs are of hematopoietic origin and
play crucial roles in the defense of CNS tissue integrity. The
activated microglia can adopt an ‘‘amoeboid’’ phenotype and
produce an enormous array of pro-inflammatory mediators,
including cytokines, chemokines, and reactive oxygen spe-
cies, that contribute to the clearance of pathogens and dam-
aged cells. Prolonged or excessive MG activation, however,
could result in pathological forms of inflammation that con-
tribute to the progression of several CNS diseases [46]. In
this study, we prepared MGs from the brain of newborn (1–3
days old) mice to investigate their morphology, phenotype,
phagocytic activity, pro- and anti-inflammatory mediator
production capacity, and antigen-presenting ability in the
presence or absence of activating stimuli and then ex-
amined how these are regulated by MSCs.
We found that MSCs are able to alter the ratio of IL-10
and TNF-a in favor of the anti-inflammatory cytokine IL-10
in the culture supernatants of MGs on LPS stimulation and
under yeast cell or apoptotic thymocyte ingestion. More-
over, the amount of PGE2 changes in a parallel manner with
IL-10 in the cocultures. Spatial separation of MGs and
MSCs in the transwell slightly ameliorates, but does not
eliminate this effect of MSCs. This is consistent with earlier
reports indicating that MSCs can shift MGs from an
FIG. 7. MSCs have an opposite effect on the expression of IL-1b and NALP3 by microglia. MGs (105/well) were cultured
alone or with MSCs (104/well) in the presence or absence of 10 mg/mL LPS in cocultures or in a transwell arrangement for
5 h. RNA samples were isolated using Trizol reagent. After purification and reverse transcription, IL-1b (A)- and NALP3
(C)-specific real-time PCR was performed. Supernatants were also collected, and the amount of IL-1b protein was measured
with quantitative ELISAs (B). Values are expressed as mean – standard deviation of three independent experiments
(*P < 0.05 compared with MG control).
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inflammatory (M1-like) into an anti-inflammatory (M2-
like) phenotype [26,31,36] mainly through COX-2 mediated
production of PGE2 and possibly some other soluble factors
[35,37]. Similar PGE2-mediated interaction was also de-
scribed between other tissue macrophages and MSCs in
vitro [12], as well as in vivo [43]. In addition, the MSC-
induced shift in microglia polarization was further affirmed
by the fact that MGs express a high amount of Arg1, another
molecule typical for M2-like phagocytes, regardless of the
presence or absence of LPS in the cocultures. It is note-
worthy that our findings differ from those reported by Tseng
et al. [38], because in their work MSCs did not affect the
expression of Arg1 by microglia. The discrepancy between
studies by Tseng et al. [38] and those in our work could be
explained by differences in the source of MGs (rat vs. mouse)
and the concentration of LPS (100 ng/mL vs. 10mg/mL) used
in the cocultures.
More importantly, we could clearly see that MSCs
themselves are able to induce some kind of microglia acti-
vation without any further stimuli. MGs had a larger-sized
(‘‘amoeboid’’ phenotype), increased phagocytic activity,
and mannose receptor (CD206) expression in the presence
of MSCs compared with MGs cultured alone. This is con-
sistent with the study by Kim and Hematti [26] showing
that human MSCs can increase the phagocytic activity and
the expression of CD206 molecules by monocyte-derived
macrophages. MSC-stimulated phagocytosis of apoptotic
cells and zymosan particles by other tissue macrophages
was also observed by Maggini et al. [12] and Zhang et al.
[27], respectively. Moreover, we also found a significant
amount of soluble mediators, especially IL-10 and PGE2, in
the supernatants of MGs cocultured with MSCs. Con-
comitantly, a low level of TNF-a production was also ob-
served. These data, along with the MSC-induced expression
of Arg1 enzyme by microglia (see above bAU5), indicate that
stem/stromal cells are indeed able to induce an MG phe-
notype with several characteristics of alternatively activated
(M2) phagocytes without any additional pro-inflammatory
stimuli. The real picture, however, is much more compli-
cated. A relatively high amount of two pro-inflammatory
mediators, MCP-1/CCL2 and IL-1b, are also expressed by
MGs on MSC coculture. We can only speculate that due
to the fact that mononuclear phagocytes with various phe-
notypic polarization are crucial for tissue repair and re-
generation [47,48], the MCP-1/CCL2-induced microglia
accumulation at the site of tissue injury or inflammation
could have a beneficial effect on the repair process. On the
other hand, the IL-1b secretion by MGs in the presence of
stem cells is consistent with an earlier report [35] and could
be explained by two facts. First, IL-1b, as a powerful pro-
inflammatory cytokine, is involved in the ‘‘licensing’’ of
MSCs necessary to exert their immunosuppressive proper-
ties [7]. Second, based on a recent report, it could also be a
growth factor for stromal cells in vitro as well as in vivo
[49]. Interestingly, however, MSCs have an opposite effect
on the expression of NALP3 that are specific mRNAs in
MGs, especially when LPS is also present in the cocultures.
Thus, the net amount of active IL-1b protein secreted by
microglia is always limited in the presence of MSCs. The
reason to keep the expression level of NALP3 relatively
low in MGs is not yet clear but might be explained by the
cytokine-independent effects of the inflammasome under
FIG. 8. MSCs enhance the antigen-presenting capacity of
MGs. (A) 2 · 105 OVA-specific T cells were added to the
cocultures of 104 microglia (antigen-presenting cell) and 103
MSCs in the presence of various concentrations of OVA in
the indicated combinations. After 4 days of culturing, the
cells were pulsed with 1mCi 3H-thymidine, incubated for an
additional 8 h, and measured for 3H-thymidine incorpora-
tion. In this figure line, represents T cells alone,
shows MSC +T-cells, indicates MG+T-
cells, while symbolizes MG+MSC +T-cells. The
results represented in cpm are shown in the form of
mean – SD of triplicate (*P< 0.05 compared with control).
(B) 3H-thymidine incorporation of naive (CM) or mitogen
(ConA, 5 mg/mL) stimulated T cells (106/well) in the pres-
ence or absence of MSCs (5 · 104/well) (n = 3, *P < 0.05
compared with control). (C) 3H-thymidine incorporation
measured in mixed lymphocyte reaction of 2–3· 105 re-
sponder (R cell) and 2–3· 105 irradiated (30 Gy) stimulator
(S cell) splenocytes in the presence or absence of MSCs
(5 · 104/well) (n = 3, *P < 0.05 compared with control). (D)
Representative flow cytometry histograms of MGs alone
(above) or together with MSCs (below) obtained using APC-
conjugated monoclonal antibodies against CD86 (black
lines) compared with the corresponding isotype control
(shaded in gray). CM, complete medium; ConA, conca-
navalin A; CPM, counts per minute; OVA, ovalbumin.
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conditions of cellular stress. Too high an NALP3 level could
be dangerous for microglia by inducing pyroptosis, a cas-
pase-1-dependent form of programmed cell death [50].
In line with this, Licandro et al. [51] recently suggested that
NALP3 modulates a number of signal pathways involved in
DNA damage response and apoptosis.
Finally, the most intriguing aspect of this study is the
enhanced proliferation of in vivo primed, antigen-specific T
lymphocytes in MG–MSC cocultures, that is, the increased
antigen-presenting ability of microglia on MSC coculture.
Notably, MSCs are able to increase the expression of cost-
imulatory molecule CD86, but not MHC class II antigens by
MGs in our experimental settings. This property of MSCs is
surprising, because several earlier reports indicated their
opposite effect on the antigen-presenting ability of dendritic
cells [52,53]. Moreover, when thyoglicolate-elicited mouse
peritoneal macrophages were cocultured with MSCs in the
presence of LPS, impaired antigen presentation and reduced
surface expression of MHC class II, CD80, and CD86
molecules were observed [12]. Maggini et al. [12], however,
measured primary T-cell response using CD4 + splenocytes
derived from an OVA-specific T-cell receptor transgenic
(OT-II) mouse. GM-CSF-treated human monocytes also
showed reduced CD40, CD80, and CD86 expression, but
increased MHC class II expression in the presence of MSCs
[54]. By contrast, a previous work has demonstrated that
MSCs do not inhibit T-cell proliferation when they are
added to recall antigen-stimulated human peripheral blood
mononuclear cells in vitro [55]. In addition, mouse MSCs
are able to augment naive CD4 + , as well as CD8 + T-cell
proliferation through the MCP-1/CCL2–CCL2 receptor
pathway when a low MSC:T-cell ratio (1:10) is used in the
cultures [56]. Moreover, apart from the effects on antigen-
presenting ability and CD86 expression of microglia, MSCs
also slightly increased the ratio of CD4 +CD25highFoxp3 +
(regulatory) T-cells in the cocultures, another well-established
function of these stem/stromal cells in vitro [57,58] as well
as in vivo [59]. Therefore, we suggest that these conflicting
results might be explained by differences regarding cell
types (microglia vs. peritoneal macrophage; naı¨ve vs. anti-
gen-experienced T cell), cell source (mouse vs. human), and
the presence or absence of additional pro-inflammatory stim-
uli (eg, LPS) in the cocultures.
In conclusion, we found that MSCs induce a mixed
microglia phenotype defined as Arg1-high, CD86-high,
CD206-high, IL-10-high, PGE2-high, MCP-1/CCL2-high,
IL-1b-moderate, NALP-3-low, and TNF-a-low cells. These
MSC-elicited MGs have high phagocytic activity and anti-
gen-presenting ability. LPS is able to shape this MG phe-
notype quantitatively, but not qualitatively in the presence
of MSCs. This unique polarization state resembles a novel
regulatory microglia phenotype, which might contribute
to the resolution of inflammation and to tissue repair in the
CNS.
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Supplementary Data
SUPPLEMENTARY FIG. S1. Changes in the morphology and spreading of MGs in the presence of MSCs. 105 MGs
derived from CD1 mice were incubated alone (A, C) or in the presence of 104 BM MSCs (B, D) for 48 h, then fixed with
paraformaldehyde, and stained with Giemsa solution (A, B) or isolectin B4 (C, D). For fluorescent images, CX3CR1
+ /GFP
MGs were cultured alone (E) or in the presence of 104 BM MSCs (F) for 48 h. BM, bone marrow; MGs, microglial cells;
MSCs, mesenchymal stem cells.
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SUPPLEMENTARY FIG. S2. Representative photo of
microglia (A) or microglia cocultured with MSCs (B) after
phagocytosis of yeast cells.
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SUPPLEMENTARY FIG. S3. The percentage of CD4 +CD25highFoxp3 + regulatory T cells increased in the cocultures
of MSCs and microglia. Representative dot plots of ovalbumin-specific CD4 + T cells for CD25 and Foxp3 markers by flow
cytometry in the presence of MGs (A) or microglia +MSCs (B).
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